CAMP

CAMP4 THERAPEUTICS CORPORATION

Contracts

Total Value

Stock Metrics

5.6%

Short % Float

8.4d to cover · Moderate squeeze

79.6%

Inst % Float

10 holders · 2026-06-30

Janus Henderson Gr

Top Holder

10.1% of float

26.5M sh

Public Float

49/100

Dilution Score

Medium

40 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

49/100

MEDIUM

Inst: 79.58% · Top: Janus Henderson Group PLC

Biotech Analytics

Biotech / Pharma

12.3

Squeeze risk: MODERATEBiotech Grade: F

Insider Buying0

Publications95

Dilution Risk49

Clinical Trials4

Short Interest30